
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
We are seeking a motivated and experienced Clinical Data Management professional to serve as the sponsor-side data management lead for assigned clinical studies within our growing development portfolio.
Reporting to the Senior Director of Data Management, this role is responsible for driving study-level data management activities from study start-up through database lock while ensuring high-quality, inspection-ready clinical data. The Manager/Senior Manager will work closely with Clinical Operations, Biostatistics, Statistical Programming, Medical, Regulatory, and external partners to support the successful execution of clinical trials.
This role is ideal for an experienced clinical data manager who enjoys hands-on study ownership, cross-functional collaboration, and helping advance innovative therapies in a fast-paced biotechnology environment.
Primary Responsibilities:
Lead Study-Level Data Management Activities
CRO and Vendor Oversight
Database and Data Quality Management
Inspection Readiness and Cross-Functional Partnership
Qualifications:
Preferred Qualifications:
The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.

Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes.
Our dream is to provide life-long cures for patients suffering from serious diseases.
The Beam Team Is:
• A community of fearless innovators
• Rigorous and honest in our research
• Listening with open minds
• Committed to each other